126 related articles for article (PubMed ID: 2937563)
1. Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
Chemioterapia; 1985 Dec; 4(6):454-9. PubMed ID: 2937563
[TBL] [Abstract][Full Text] [Related]
2. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
4. Modulation of fluoropyrimidine cytotoxicity by methotrexate or 5-methyltetrahydrofolate in human leukemia cells in vitro.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
Chemioterapia; 1984 Dec; 3(6):343-9. PubMed ID: 6241507
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
Grant S; Cadman E
Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
[TBL] [Abstract][Full Text] [Related]
6. Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition.
Yin MB; Rustum YM
Cancer Commun; 1991 Feb; 3(2):45-51. PubMed ID: 1825284
[TBL] [Abstract][Full Text] [Related]
7. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
Fernandes DJ; Cranford SK
Biochem Pharmacol; 1985 Jan; 34(1):125-32. PubMed ID: 3155614
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid.
Fernandes DJ; Cranford SK
Cancer Res; 1986 Apr; 46(4 Pt 1):1741-7. PubMed ID: 2936450
[TBL] [Abstract][Full Text] [Related]
9. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
Keyomarsi K; Moran RG
Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
[TBL] [Abstract][Full Text] [Related]
10. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
[TBL] [Abstract][Full Text] [Related]
11. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
Takimoto CH; Tan YY; Cadman EC; Armstrong RD
Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.
Benson AB; Trump DL; Cummings KB; Fischer PH
Biochem Pharmacol; 1985 Nov; 34(21):3925-31. PubMed ID: 2933042
[TBL] [Abstract][Full Text] [Related]
14. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.
Romanini A; Lin JT; Niedzwiecki D; Bunni M; Priest DG; Bertino JR
Cancer Res; 1991 Feb; 51(3):789-93. PubMed ID: 1988119
[TBL] [Abstract][Full Text] [Related]
15. Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides.
Bapat AR; Zarow C; Danenberg PV
J Biol Chem; 1983 Apr; 258(7):4130-6. PubMed ID: 6220000
[TBL] [Abstract][Full Text] [Related]
16. Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interaction.
Sobrero A; Romanini A; Russello O; Nicolin A; Rosso R; Bertino JR
Eur J Cancer Clin Oncol; 1989 Jun; 25(6):977-82. PubMed ID: 2526736
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
18. Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.
Sobrero A; Aschele C; Guglielmi A; Nobile MT; Rosso R
J Chemother; 1990 Feb; 2 Suppl 1():12-6. PubMed ID: 2142213
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of fluoropyrimidine inhibition of cell growth by leucovorin and deoxynucleosides in a human squamous cell carcinoma cell line.
Chang YM; Bertino JR
Cancer Invest; 1989; 7(6):557-63. PubMed ID: 2534282
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
Aschele C; Sobrero A; Faderan MA; Bertino JR
Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
